Synopsis
Synopsis
0
CEP/COS
0
JDMF
0
EU WC
0
KDMF
0
API
0
FDF
0
FDF Dossiers
0
FDA Orange Book
0
Europe
0
Canada
0
Australia
0
South Africa
0
Listed Dossiers
DRUG PRODUCT COMPOSITIONS
0
US Patents
0
US Exclusivities
0
Health Canada Patents
0
Stock Recap #PipelineProspector
0
Weekly News Recap #Phispers
0
News #PharmaBuzz
US Medicaid
NA
Annual Reports
NA
Finished Drug Prices
NA
1. 6-trp-10-n-et-glynh2-lhrh
2. D-trp(6)-n-et-d-glynh2(10)-lhrh
3. Deslorelin Acetate
4. Gnrh, Trp(6)-n-et-glynh2(10)-
5. Lhrh, Trp(6)-n-et-glynh2(10)-
6. Lhrh, Tryptophyl(6)-n-ethylglycinamide(10)-
7. Ovuplant
8. Somagard
1. 57773-65-6
2. Somagard
3. D-trp Lhrh-pea
4. D-trp-lhrh-pea
5. Bachem 9022
6. Tkg3i66tve
7. 1-9-luteinizing Hormone-releasing Factor (swine),6-d-tryptophan-9-(n-ethyl-l-prolinamide)-
8. 5-oxo-l-prolyl-l-histidyl-l-tryptophyl-l-seryl-l-tyrosyl-d-tryptophyl-l-leucyl-l-arginyl-n-ethyl-l-prolinamide
9. Deslorelina
10. Desloreline
11. Deslorelinum
12. Ncgc00167516-01
13. Unii-tkg3i66tve
14. Desloreline [inn-french]
15. Deslorelinum [inn-latin]
16. Deslorelina [inn-spanish]
17. Gnrh (d-trp6,pro9-net)
18. Deslorelin [usan:inn:ban]
19. (d-trp6,pro9-nhet)lh-rh
20. (d-trp6,des-gly10)-lh-rh Ethylamide
21. (de-gly10,d-trp6,pro-nhet)-lh-rh
22. (des-gly10(d-tro6)-lh-rh Ethylamide
23. Lhrh-t
24. (d-trp(sub 6)-pro(sup 9)-net)-gnrh
25. Deslorelin [mi]
26. Deslorelin [inn]
27. Deslorelin (usan/inn)
28. Deslorelin [usan]
29. (d-trp6,des-gly-nh210)-lh-rh Ethylamide
30. D-trp(sup 6)-pro(sup 9)-n-ethylamide-lhrh
31. (d-trp(sup 6)-pro(sup 9))-lhrh Ethylamide
32. H 4065
33. Deslorelin [mart.]
34. Deslorelin [who-dd]
35. Schembl59413
36. Gtpl9343
37. Chembl2365665
38. Dtxsid2048323
39. Schembl19409316
40. Bdbm84726
41. Chebi:177570
42. (d-trp(sub 6)-pro(sup 9)-net)-gonadotropin Releasing Hormone
43. Gonadotropin Releasing Hormone, (d-trp(sup 6)-pro(sup 9)-net)-
44. Des-gly-10-trp-6-ethylamide-lhrh
45. (d-trp(sup 6)-pro(sup 9))-luteinizing Hormone-releasing Hormone Ethylamide
46. Akos015994649
47. Cs-5746
48. Db11510
49. Hs-2009
50. 6-d-tryptophan-9-(n-ethyl-l-prolinamide)-1-9-luteinizing Hormone-releasing Factor (swine)
51. Gnrh, Trp(6)-n-et-pronh2(9)-
52. Lhrh, Trp(6)-n-et-pronh2(9)-
53. Ncgc00167516-02
54. Ncgc00167516-03
55. Gnrh, Des-gly(10)-trp(6)-ethylamide-
56. Hy-12556
57. Lhrh, Des-gly(10)-trp(6)-ethylamide-
58. 6-trp-9-n-et-pro-10-des-glynh2-lhrh
59. 6-d-phenylalanine-9-(n-ethyl-l-prolinamide)-
60. D03694
61. 773d656
62. Des-gly10,(d-trp6)luteinizing Hormone*releasing H
63. Lhrh, Des-glycyl(10)-tryptophyl(6)-ethylamide-
64. Q5264591
65. (d-trp6-pro9-net)luteinizing Hormone-releasing Factor
66. (d-trp(sup 6),des-gly(sup 10))-lh-rh Ethylamide
67. [des-gly10, D-trp6]-lh-rh Ethylamide, >=97% (hplc)
68. Lhrh, Tryptophyl(6)-n-ethylprolinamide(9)-des-glycinamide(10)-
69. 1-9-luteinizing Hormone-releaasing Factor (swine), 6-d-tryptophan-9-(n-ethyl-l-prolinamide)-
70. Luteinizing Hormone-releasing Factor (pig), 6-d-tryptophan-9-(n-ethyl-l-prolinamide)-10-deglycinamide-
71. Luteinizing Hormone-releasing Factor, 6-d-tryptophan-9-(n-ethyl-l-prolinamide)-10-deglycinamide-
| Molecular Weight | 1282.4 g/mol |
|---|---|
| Molecular Formula | C64H83N17O12 |
| XLogP3 | 1.1 |
| Hydrogen Bond Donor Count | 16 |
| Hydrogen Bond Acceptor Count | 14 |
| Rotatable Bond Count | 32 |
| Exact Mass | 1281.64071115 g/mol |
| Monoisotopic Mass | 1281.64071115 g/mol |
| Topological Polar Surface Area | 447 Ų |
| Heavy Atom Count | 93 |
| Formal Charge | 0 |
| Complexity | 2610 |
| Isotope Atom Count | 0 |
| Defined Atom Stereocenter Count | 9 |
| Undefined Atom Stereocenter Count | 0 |
| Defined Bond Stereocenter Count | 0 |
| Undefined Bond Stereocenter Count | 0 |
| Covalently Bonded Unit Count | 1 |
Enzyme Inhibitors
Compounds or agents that combine with an enzyme in such a manner as to prevent the normal substrate-enzyme combination and the catalytic reaction. (See all compounds classified as Enzyme Inhibitors.)
API SUPPLIERS
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]
USDMF
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]NDC API
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]Listed Suppliers
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]API Reference Price
API Imports and Exports
| Importing Country | Total Quantity (KGS) |
Average Price (USD/KGS) |
Number of Transactions |
|---|
Upgrade, download data, analyse, strategize, subscribe with us 
Digital Content
DATA COMPILATION #PharmaFlow
REF. STANDARDS & IMPURITIES
ABOUT THIS PAGE
A Deslorelin manufacturer is defined as any person or entity involved in the manufacture, preparation, processing, compounding or propagation of Deslorelin, including repackagers and relabelers. The FDA regulates Deslorelin manufacturers to ensure that their products comply with relevant laws and regulations and are safe and effective to use. Deslorelin API Manufacturers are required to adhere to Good Manufacturing Practices (GMP) to ensure that their products are consistently manufactured to meet established quality criteria.
click here to find a list of Deslorelin manufacturers with USDMF, JDMF, KDMF, CEP, GMP, COA and API Price related information on PhamaCompass.
A Deslorelin supplier is an individual or a company that provides Deslorelin active pharmaceutical ingredient (API) or Deslorelin finished formulations upon request. The Deslorelin suppliers may include Deslorelin API manufacturers, exporters, distributors and traders.
click here to find a list of Deslorelin suppliers with USDMF, JDMF, KDMF, CEP, GMP, COA and API Price related information on PharmaCompass.
A Deslorelin DMF (Drug Master File) is a document detailing the whole manufacturing process of Deslorelin active pharmaceutical ingredient (API) in detail. Different forms of Deslorelin DMFs exist exist since differing nations have different regulations, such as Deslorelin USDMF, ASMF (EDMF), JDMF, CDMF, etc.
A Deslorelin DMF submitted to regulatory agencies in the US is known as a USDMF. Deslorelin USDMF includes data on Deslorelin's chemical properties, information on the facilities and procedures used, and details about packaging and storage. The Deslorelin USDMF is kept confidential to protect the manufacturer’s intellectual property.
click here to find a list of Deslorelin suppliers with USDMF on PharmaCompass.
National Drug Code is a comprehensive database maintained by the FDA that contains information on all drugs marketed in the US. This directory includes information about finished drug products, unfinished drug products, and compounded drug products, including those containing Deslorelin as an active pharmaceutical ingredient (API).
The FDA updates the NDC directory daily. The NDC numbers for Deslorelin API and other APIs are published in this directory by the FDA.
The NDC unfinished drugs database includes product listing information submitted for all unfinished drugs, such as active pharmaceutical ingredients (APIs), drugs intended for further processing and bulk drug substances for compounding.
Pharmaceutical companies that manufacture Deslorelin as an active pharmaceutical ingredient (API) must furnish the FDA with an updated record of all drugs that they produce, prepare, propagate, compound, or process for commercial distribution in the US at their facilities.
The NDC directory also contains data on finished compounded human drug products that contain Deslorelin and are produced by outsourcing facilities. While these outsourcing facilities are not mandated to assign a Deslorelin NDC to their finished compounded human drug products, they may choose to do so.
click here to find a list of Deslorelin suppliers with NDC on PharmaCompass.
Deslorelin Active pharmaceutical ingredient (API) is produced in GMP-certified manufacturing facility.
GMP stands for Good Manufacturing Practices, which is a system used in the pharmaceutical industry to make sure that goods are regularly produced and monitored in accordance with quality standards. The FDA’s current Good Manufacturing Practices requirements are referred to as cGMP or current GMP which indicates that the company follows the most recent GMP specifications. The World Health Organization (WHO) has its own set of GMP guidelines, called the WHO GMP. Different countries can also set their own guidelines for GMP like China (Chinese GMP) or the EU (EU GMP).
PharmaCompass offers a list of Deslorelin GMP manufacturers, exporters & distributors, which can be sorted by USDMF, JDMF, KDMF, CEP (COS), WC, API price, and more, enabling you to easily find the right Deslorelin GMP manufacturer or Deslorelin GMP API supplier for your needs.
A Deslorelin CoA (Certificate of Analysis) is a formal document that attests to Deslorelin's compliance with Deslorelin specifications and serves as a tool for batch-level quality control.
Deslorelin CoA mostly includes findings from lab analyses of a specific batch. For each Deslorelin CoA document that a company creates, the USFDA specifies specific requirements, such as supplier information, material identification, transportation data, evidence of conformity and signature data.
Deslorelin may be tested according to a variety of international standards, such as European Pharmacopoeia (Deslorelin EP), Deslorelin JP (Japanese Pharmacopeia) and the US Pharmacopoeia (Deslorelin USP).
LOOKING FOR A SUPPLIER?
